Enanta Pharmaceuticals Inc (NASDAQ:ENTA) price on Thursday, July 03, fall -1.00% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.89.
A look at the stock’s price movement, the close in the last trading session was $7.97, moving within a range at $7.73 and $8.03. The beta value (5-Year monthly) was 0.772. Turning to its 52-week performance, $17.24 and $4.09 were the 52-week high and 52-week low respectively. Overall, ENTA moved 9.74% over the past month.
Enanta Pharmaceuticals Inc’s market cap currently stands at around $168.66 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ENTA is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend ENTA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ENTA’s current price about 5.64% and 22.25% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 67.32, while 7-day volatility ratio is 4.67% and 6.13% in the 30-day chart. Further, Enanta Pharmaceuticals Inc (ENTA) has a beta value of 0.88. Analysts have given the company’s stock an average 52-week price target of $24, forecast between a low of $24 and high of $24. Looking at the price targets, the low is -204.18% off current price level while to achieve the yearly target high, price needs to move -204.18%. Nonetheless, investors will most likely welcome a -204.18% jump to $24 which is the analysts’ median price.
If we refocus on Enanta Pharmaceuticals Inc (NASDAQ:ENTA), historical trading data shows that trading volumes averaged 0.15 over the past 10 days and 188.57K over the past 3 months. The company’s latest data on shares outstanding shows there are 21.38 million shares.
The 7.09% of Enanta Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 87.51% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.5 million on 2025-06-13, giving us a short ratio of 14.96. The data shows that as of 2025-06-13 short interest in Enanta Pharmaceuticals Inc (ENTA) stood at 1242.0 of shares outstanding, with shares short falling to 2.85 million registered in 2025-05-15. Current price change has pushed the stock -39.63% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ENTA stock continues to rise going into the next quarter.
